Is New Always Better? Apixaban vs. Warfarin and CKD Progression
Atrial fibrillation (AF) is the most common arrhythmia in patients with chronic kidney disease (CKD), with a prevalence of nearly 24.5%. This is over 2 times higher than [...]
chronic kidney disease
Association of Blood Pressure With the Progression of CKD: Are We Any Further Forward?
Lowering blood pressure (BP) is beneficial in patients with chronic kidney disease (CKD) from a cardiovascular protection point of view, and has formed the basis of our [...]
Highlights from the July 2021 Issue
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic [...]
Will You Take the Blue or Red Pill?
Calcium channel blockers (CCBs) and renin-angiotensin-system inhibitors (RASi) are two classes of antihypertensive medications frequently used as initial therapy for [...]
COVID-19 Pandemic and CKD Population Health: An Interview
In a recent Policy Forum published in AJKD, Tummalapalli et al outline COVID-19–related payment and regulatory changes and their implications for CKD care delivery and the [...]